Beneficiary: Dr Peter Riis Hansen, Department of Cardiology P, Gentofte Hospital, Denmark
Grant: DKK 4,200,000
Psoriasis patients have increased risk of cardiovascular disease (CVD), which still carries high morbidity and mortality in western societies, and is increasing dramatically in the emerging economies.
Consequently, research directed at the interface between psoriasis and CVD, from the level of epidemiological studies to basic experimental research, is of paramount importance in order to improve overall care for psoriasis patients, as well as supporting the need to seek help to receive treatment.
A research project led by Dr Peter Riis Hansen, Gentofte Hospital,
Department of Cardiology P, Denmark, will help to:
- Inform and motivate dermatologists to play a pivotal role in screening and helping patients with psoriasis to prevent an increased risk of CVD
- Motivate patients with psoriasis to, firstly, seek treatment and assessment of their CVD risk and, secondly, improve treatment of psoriasis to reduce the overall immune activation
- Establish a murine model of psoriasis and CVD that is suitable for mechanistic studies and preclinical drug evaluation
- Identify new markers of psoriasis and/or CVD activity that may be relevant for clinical use.
Khalid U et al. Psoriasis and new-onset diabetes: a Danish nationwide cohort study. Diabetes Care 2013;6:2404-7
Khalid U et al. Psoriasis and risk of heart failure: a nation-wide cohort study. Eur J Heart Fail 2014;16:743-8
Khalid U et al. Sarcoidosis in patients with psoriasis: a population-based cohort study. PLoS ONE 2014;9(10)e109632
Khalid U et al. Increased risk of aortic valve stenosis in patients with psoriasis: A nation-wide cohort study. Eur Heart J 2015;36:2177-83
Khalid U et al. A nationwide study of the risk of abdominal aortic aneurysms in patients with psoriasis
Madsen M et al. Effects of TPA-induced experimental psoriasis-like skin inflammation in atherosclerosis-prone apoE knock-out mice. BMC Dermatology 2015